AllianceBernstein Portfolio holdings
AllianceBernstein (AB), formed in 2000 through the merger of Alliance Capital and Bernstein, is a global asset management firm headquartered in Nashville, Tennessee, managing over $759 billion in assets as of late 2024 for institutional investors, financial advisors, and individuals. Known for its research-driven approach, AB offers a diverse range of investment strategies, including equities, fixed income, alternatives, and multi-asset solutions, with a strong emphasis on active management and ESG (environmental, social, governance) integration. The firm, which relocated its headquarters from New York City to Nashville in 2021, operates globally with significant operations in New York, London, and Asia, leveraging its Bernstein Research arm for deep market insights. With a workforce of over 4,700 and a partnership structure led by CEO Seth Bernstein, AB combines a legacy of rigorous analysis with a modern focus on sustainable investing and client outcomes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$621M |
| 2 |
Visa
V
|
+$574M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$542M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
+$525M |
| 5 |
Amazon
AMZN
|
+$441M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$693M |
| 2 |
Texas Instruments
TXN
|
+$477M |
| 3 |
ZEN
ZENDESK INC
ZEN
|
+$300M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
+$235M |
| 5 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$230M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.41% |
| 2 | Healthcare | 14.87% |
| 3 | Consumer Discretionary | 13.28% |
| 4 | Financials | 12.61% |
| 5 | Communication Services | 10.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CCF
2626
DELISTED
Chase Corporation
CCF
| $705K | ﹤0.01% |
6,900
-1,000
| -13% | -$111K |
|
2627
MiMedx Group
MDXG
$649M
| $702K | ﹤0.01% |
115,900
-10,000
| -8% | -$113K |
|
2628
Privia Health
PRVA
$3.13B
| $700K | ﹤0.01% |
29,700
| – | – |
|
|
LORL
2629
DELISTED
Loral Space and Communications, Inc.
LORL
| $698K | ﹤0.01% |
16,237
-1,600
| -9% | -$62.1K |
|
2630
C3.ai
AI
$1.38B
| $697K | ﹤0.01% |
15,034
+708
| +5% | +$36K |
|
|
FMTX
2631
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
| $696K | ﹤0.01% |
30,000
-2,300
| -7% | -$54.4K |
|
2632
CAE Inc. Common Shares
CAE
$8.48B
| $693K | ﹤0.01% |
23,209
+171
| +0.7% | +$5.06K |
|
2633
Metropolitan Bank Holding Corp
MCB
$1.14B
| $687K | ﹤0.01% |
8,144
-400
| -5% | -$29.1K |
|
2634
Banc of California
BANC
$3.27B
| $685K | ﹤0.01% |
37,072
-7,970
| -18% | -$139K |
|
2635
Copa Holdings
CPA
$5.71B
| $684K | ﹤0.01% |
8,406
+445
| +6% | +$33.3K |
|
|
CSTA
2636
DELISTED
Constellation Acquisition Corp I
CSTA
| $683K | ﹤0.01% |
70,000
| – | – |
|
|
MRSN
2637
DELISTED
Mersana Therapeutics
MRSN
| $679K | ﹤0.01% |
2,880
| – | – |
|
2638
CarParts.com
PRTS
$42.4M
| $677K | ﹤0.01% |
4,340
| – | – |
|
2639
MGP Ingredients
MGPI
$400M
| $675K | ﹤0.01% |
10,370
-2,010
| -16% | -$129K |
|
2640
Karyopharm Therapeutics
KPTI
$161M
| $674K | ﹤0.01% |
7,722
| – | – |
|
2641
Dorian LPG
LPG
$1.9B
| $674K | ﹤0.01% |
54,282
-1,210
| -2% | -$15.1K |
|
|
JAMF
2642
DELISTED
Jamf
JAMF
| $672K | ﹤0.01% |
17,436
-8,902
| -34% | -$306K |
|
|
KZR
2643
DELISTED
Kezar Life Sciences
KZR
| $671K | ﹤0.01% |
7,770
| – | – |
|
2644
Scansource
SCSC
$1.16B
| $671K | ﹤0.01% |
19,300
-5,709
| -23% | -$175K |
|
2645
OneSpan
OSPN
$572M
| $666K | ﹤0.01% |
35,489
-9,010
| -20% | -$191K |
|
|
CNR
2646
Core Natural Resources Inc
CNR
$4.02B
| $665K | ﹤0.01% |
25,560
-1,150
| -4% | -$25.3K |
|
2647
Nokia
NOK
$49.9B
| $663K | ﹤0.01% |
121,735
-5,881
| -5% | -$34.1K |
|
|
SHOE
2648
Shoe Station Group
SHOE
$431M
| $663K | ﹤0.01% |
20,460
-780
| -4% | -$27.2K |
|
2649
SI-BONE Inc
SIBN
$795M
| $662K | ﹤0.01% |
30,900
| – | – |
|
2650
Helix Energy Solutions
HLX
$1.35B
| $661K | ﹤0.01% |
170,255
-3,567,712
| -95% | -$14.7M |
|
Similar funds
AllianceBernstein's Q3 2021 Portfolio in Review
As of Q3 2021, AllianceBernstein held 3,430 positions worth $253B, up 1.8% from $249B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
AllianceBernstein's Q3 2021 filing shows 114 new, 1,102 increased, 1,623 reduced and 152 closed positions. Its largest new stake was Freshworks: 2,094,708 shares worth $89.4M. The largest sale was Alphabet (Google) Class C, an estimated $693M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- AllianceBernstein's largest Q3 2021 buy was Freshworks: 2,094,708 shares worth $89.4M.
- AllianceBernstein added most to Qualcomm in Q3 2021, an estimated $621M increase.
- AllianceBernstein's biggest Q3 2021 reduction was Alphabet (Google) Class C, cutting an estimated $693M.
- AllianceBernstein fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $230M.
- AllianceBernstein's ten largest holdings make up 25% of its $253B portfolio in Q3 2021.
- AllianceBernstein opened 114 new positions and closed 152 in Q3 2021.
- AllianceBernstein's portfolio value rose 1.8% quarter-over-quarter to $253B.
Based on AllianceBernstein's 13F filing for Q3 2021, filed 10 Nov 2021.